Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MIN JANICE LU

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1568488526
CMS profile
161933
Location
STANFORD, CA

General Payments · PY2019–2025

$39,523.96

  • Reported across 54 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$9,479.35

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $3,437.70 3
Genentech USA, Inc. $3,168.79 4
Stemline Therapeutics Inc. $2,845.14 3
Incyte Corporation $27.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $778.75 8
PY2020 $9,522.25 6
PY2021 $10,261.92 7
PY2022 $1,675.73 4
PY2023 $6,291.35 9
PY2024 $1,514.61 9
PY2025 $9,479.35 11

Payment records · PY2025 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $842.70 02/14/2025 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 06/30/2026 1206455372 CMS
AstraZeneca Pharmaceuticals LP $135.00 12/11/2025 Food and Beverage Undisputed 06/30/2026 1206476966 CMS
AstraZeneca Pharmaceuticals LP $2,460.00 12/22/2025 Consulting Fee Undisputed 06/30/2026 1207054522 CMS
Genentech USA, Inc. $2,320.00 03/06/2025 Consulting Fee Undisputed 06/30/2026 1211553043 CMS
Genentech USA, Inc. $500.46 03/06/2025 Travel and Lodging Undisputed 06/30/2026 1211553046 CMS
Genentech USA, Inc. $239.49 03/06/2025 Food and Beverage Undisputed 06/30/2026 1211553050 CMS
Genentech USA, Inc. $108.84 08/20/2025 Food and Beverage Undisputed 06/30/2026 1211553053 CMS
Incyte Corporation $27.72 03/11/2025 Food and Beverage Undisputed 06/30/2026 1226017340 CMS
Stemline Therapeutics Inc. $46.72 08/22/2025 Food and Beverage Undisputed 06/30/2026 1244100026 CMS
Stemline Therapeutics Inc. $2,730.00 08/22/2025 Consulting Fee Undisputed 06/30/2026 1244100029 CMS
Stemline Therapeutics Inc. $68.42 08/22/2025 Food and Beverage Undisputed 06/30/2026 1244100033 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.